Latham and Skadden lead on £4.6bn Abcam acquisition
Advisers from Latham & Watkins and Skadden Arps Slate Meagher & Flom have led on US conglomerate Danaher Corporation’s recent acquisition of Cambridge-based life science innovator Abcam in a $5.7bn transaction. Since Abcam’s AIM delisting in December 2022, Latham is understood to have been working closely with the company’s executive board as it faced calls […]